OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In Vivo Targeting of CXCR4—New Horizons
Margret Schottelius, Ken Herrmann, Constantin Lapa
Cancers (2021) Vol. 13, Iss. 23, pp. 5920-5920
Open Access | Times Cited: 32
Margret Schottelius, Ken Herrmann, Constantin Lapa
Cancers (2021) Vol. 13, Iss. 23, pp. 5920-5920
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Radiotheranostics in oncology: Making precision medicine possible
Eric O. Aboagye, Tara Barwick, Uwe Haberkorn
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 3, pp. 255-274
Open Access | Times Cited: 72
Eric O. Aboagye, Tara Barwick, Uwe Haberkorn
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 3, pp. 255-274
Open Access | Times Cited: 72
Revolutionizing Neurocare: Biomimetic Nanodelivery Via Cell Membranes
Jun Liao, Lidong Gong, Qingqiang Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 31
Jun Liao, Lidong Gong, Qingqiang Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 31
Next generation radiotheranostics promoting precision medicine
Kelsey L. Pomykala, Boris Hadaschik, Oliver Sartor, et al.
Annals of Oncology (2023) Vol. 34, Iss. 6, pp. 507-519
Open Access | Times Cited: 39
Kelsey L. Pomykala, Boris Hadaschik, Oliver Sartor, et al.
Annals of Oncology (2023) Vol. 34, Iss. 6, pp. 507-519
Open Access | Times Cited: 39
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 34
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 34
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
Shunshun Bao, Mohammad Darvishi, Ali H. Amin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7945-7968
Closed Access | Times Cited: 18
Shunshun Bao, Mohammad Darvishi, Ali H. Amin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7945-7968
Closed Access | Times Cited: 18
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2340-2340
Open Access | Times Cited: 8
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2340-2340
Open Access | Times Cited: 8
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT
Sebastian E. Serfling, Constantin Lapa, Niklas Dreher, et al.
Molecular Imaging and Biology (2022) Vol. 24, Iss. 4, pp. 659-665
Open Access | Times Cited: 21
Sebastian E. Serfling, Constantin Lapa, Niklas Dreher, et al.
Molecular Imaging and Biology (2022) Vol. 24, Iss. 4, pp. 659-665
Open Access | Times Cited: 21
Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis
Chenyu Sun, Shaodi Ma, Yue Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Chenyu Sun, Shaodi Ma, Yue Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
[99mTc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience
Matthias Konrad, Andreas Rinscheid, Georgine Wienand, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 13, pp. 3937-3948
Open Access | Times Cited: 10
Matthias Konrad, Andreas Rinscheid, Georgine Wienand, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 13, pp. 3937-3948
Open Access | Times Cited: 10
Advances with radiopharmaceutical therapy in cancer
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Targeting the chemokine receptor CXCR4 for cancer therapies
Ariana Rueda, Naroa Serna, Ramón Mangues, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Ariana Rueda, Naroa Serna, Ramón Mangues, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett’s esophagus
Sabrina Marcazzan, Marcos J. Braz Carvalho, Matthias Konrad, et al.
EJNMMI Research (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Sabrina Marcazzan, Marcos J. Braz Carvalho, Matthias Konrad, et al.
EJNMMI Research (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
(2023)
Open Access | Times Cited: 8
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
(2023)
Open Access | Times Cited: 8
Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging
Aleksander Kosmala, Simone Seifert, Simone Schneid, et al.
Molecular Imaging and Biology (2023) Vol. 25, Iss. 4, pp. 758-764
Open Access | Times Cited: 7
Aleksander Kosmala, Simone Seifert, Simone Schneid, et al.
Molecular Imaging and Biology (2023) Vol. 25, Iss. 4, pp. 758-764
Open Access | Times Cited: 7
Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications
Raghuvir H. Gaonkar, Yannik Tim Schmidt, Rosalba Mansi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8484-8497
Open Access | Times Cited: 7
Raghuvir H. Gaonkar, Yannik Tim Schmidt, Rosalba Mansi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8484-8497
Open Access | Times Cited: 7
Early, non-invasive detection of radiation-induced lung injury using PET/CT by targeting CXCR4
Jinli Pei, Kai Cheng, Tianxin Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 4, pp. 1109-1120
Closed Access | Times Cited: 7
Jinli Pei, Kai Cheng, Tianxin Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 4, pp. 1109-1120
Closed Access | Times Cited: 7
Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation
Sebastian Martin, Lennard Wendlinger, Béatrice Zitti, et al.
EJNMMI Research (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Sebastian Martin, Lennard Wendlinger, Béatrice Zitti, et al.
EJNMMI Research (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications
Daniel Kwon, Zhengxing Zhang, Jutta Zeisler, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1502-1502
Open Access | Times Cited: 11
Daniel Kwon, Zhengxing Zhang, Jutta Zeisler, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1502-1502
Open Access | Times Cited: 11
CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
Jingjing Yu, Xu Zhou, Shen Langtao
Molecules (2023) Vol. 28, Iss. 12, pp. 4707-4707
Open Access | Times Cited: 6
Jingjing Yu, Xu Zhou, Shen Langtao
Molecules (2023) Vol. 28, Iss. 12, pp. 4707-4707
Open Access | Times Cited: 6
C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Hematological Malignancies—Myeloablative Effects, Antilymphoma Activity, and Safety Profile
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine (2023) Vol. 49, Iss. 2, pp. 146-151
Open Access | Times Cited: 6
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine (2023) Vol. 49, Iss. 2, pp. 146-151
Open Access | Times Cited: 6
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Rudolf A. Werner, Alexander Haug, Christian Buske, et al.
Nuklearmedizin - NuclearMedicine (2024) Vol. 63, Iss. 02, pp. 57-61
Open Access | Times Cited: 2
Rudolf A. Werner, Alexander Haug, Christian Buske, et al.
Nuklearmedizin - NuclearMedicine (2024) Vol. 63, Iss. 02, pp. 57-61
Open Access | Times Cited: 2
Gallium-68 Labelled Radiopharmaceuticals for Imaging Inflammatory Disorders
Mariza Vorster
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 2, pp. 199-212
Closed Access | Times Cited: 10
Mariza Vorster
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 2, pp. 199-212
Closed Access | Times Cited: 10
Imaging Aldosterone-Producing Adrenocortical Carcinoma With 68Ga-Pentixafor PET/CT
Qiaoqiao Shu, Maoxue Deng, Yue Chen, et al.
Clinical Nuclear Medicine (2022) Vol. 47, Iss. 8, pp. e572-e573
Closed Access | Times Cited: 8
Qiaoqiao Shu, Maoxue Deng, Yue Chen, et al.
Clinical Nuclear Medicine (2022) Vol. 47, Iss. 8, pp. e572-e573
Closed Access | Times Cited: 8
A dataset of [68Ga]Ga-Pentixafor PET/CT images of patients with high-grade Glioma
Hessamoddin Roustaei, Nasim Norouzbeigi, Habibeh Vosoughi, et al.
Data in Brief (2023) Vol. 48, pp. 109236-109236
Open Access | Times Cited: 4
Hessamoddin Roustaei, Nasim Norouzbeigi, Habibeh Vosoughi, et al.
Data in Brief (2023) Vol. 48, pp. 109236-109236
Open Access | Times Cited: 4
Positron Emission Tomography/Computed Tomography Transformation of Oncology
Salikh Murtazaliev, Steven P. Rowe, Sara Sheikhbahaei, et al.
PET Clinics (2024) Vol. 19, Iss. 2, pp. 249-260
Closed Access | Times Cited: 1
Salikh Murtazaliev, Steven P. Rowe, Sara Sheikhbahaei, et al.
PET Clinics (2024) Vol. 19, Iss. 2, pp. 249-260
Closed Access | Times Cited: 1
